:::
| 姓名 | 黃正仲 |
|---|
| 類別 | 兼任師資 |
|---|---|
| 職稱 | 教授 |
| 研究專長 | 分子與基因影像、輻射生物、輻射細胞遺傳、核醫藥物動物模式分佈、細胞及分子生物學 |
其他著作
- 期刊論文
- 1. ChangYF, LinYY, WangHE, LiuRS, PangF, HwangJJ* (2007): Monitoring of tumor growth and metastasis potential in MDA-MB-435s-tk/luc human breast cancer xenografts. Nucl Instrum Meth A, 571, 155-159.2. Chen CC, HwangJJ*, TingG, TsengYL, WangSJ, Whang-PengJ (2007): Temporal Monitoring and Quantitative Assessment of Tumor Burden Growth Using In Vivo Bioluminescence Imaging. Nucl Instrum Meth A, 571, 437-441.3. Su YC, Chuang KH, Wang YM, Cheng CM, Lin SR, Wang JY, Hwang JJ, Chen BM, Chen KC, Rofler S, Cheng TL (2007): Gene expression imaging by enzymatic catalysis of a fluorescent probe via membrane-anchored -gluculonidase. Gene Therapy, 14, 565-574.4. LiaoAH, HwangJJ, Li CH, Cheng WF, Li PC (2007): Noninvasive tumor imaging with high-frequency ultrasound and microPET in small animals. Ultrasonic Imaging, 29, 182-194.5. ChenHW, ChangYC, Chen YJ, Huang MJ, Leu YS, Chang GH, Hwang JJ* (2008): Epstein-Barr virus infection and plasma transforming growth factor-1 levels in head and neck cancers. Acta Oto-Laryngologica, 128(10):1145-1151.6. Hsieh CH, Chen FD, Wang HE, Hwang JJ, Chang CW, Lee YJ, Gelovani JG, Liu RS (2008): Generation of destabilized herpes simplex virus type 1 thymidine kinase as transcription reporter for positron emission tomography reporter systems in molecular-genetic imaging. J Nucl Med, 49, 142-150.7. ChowTH, LinYY, HwangJJ*, WangHE, TsengYL, PangVF, WangSJ, Whang-PengJ, Ting G (2008): Diagnostic and therapeutic evaluation of 111In-vinorelbine liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model. Nucl Med Biol, 35, 623-634.8. Lee YJ, Tsai CH, Hwang JJ, Chiu SJ, Sheu TJ, Keng PC (2009): Involvement of a p53-independent and post-transcriptional up-regulation for p21WAF/CIP1 following destabilization of the actin cytoskeleton. Intl J Oncol, 34:581-589.9. Liu RS, Hsieh YJ, Ke CC, Chen FD, Hwu L, Wang FH, Hwang JJ, Chi CW, Lee CH, Yeh SH (2009): Specific activation of sodium/iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA). Anticancer Res, 29:211-222.10. Chow TH, Lin YY, Hwang JJ*, Wang HE, Tseng YL, Wang SJ, Liu RS, Lin WJ, Yang CS, Ting G (2009): Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Anticancer Res, 29:2111-2120.11. Ma KH, Huang WS, Guo YY, Peng CJ, Liu RS, Hwang JJ, Liu JC, Chen HJ, Shiue CY (2009): Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography. Neuroimage, 45:687-693.12. Lin YY, Li JL, Chang CH, Lu YC, Hwang JJ, Tseng YL, Lin WJ, Ting G, Wang HE (2009): Evaluation of pharmacokinetics of 111In-labeled VNB-liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model. Cancer Biother Radio, 24, 453-460.13. Chow TH, Lin YY, HwangJJ*, Wang HE, Tseng YL, Pang VF, Liu RS, Lin WJ, Yang CS, Ting G (2009): Therapeutic efficacy evaluation of 111In-labeled pegylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging. J Nucl Med, 50, 2073-2081.14. Lin YC, Chen HW, Kuo YC, Chang YF, Hwang JJ* (2010): Therapeutic efficacy evaluation of curcumim on human oral squamous cell carcinoma xenograft using multimodalities of molecular imaging. Am J Chin Med, 38, 343-358.15. Liao AH, Chou FI, Kuo YC, Chen HW, Kai JJ, ChangCW, F.D. Chen FD, Hwang JJ* (2010): Biodistribution of phenylboric acid derivative entrapped lipiodol and 4-borono-2-18F-fluoro-L-phenylalanine-fructose in GP7TB liver tumor bearing rats for BNCT. Appl Radiat Isotopes, 68, 422-426.16. Chuang HY, Chang YF, Hwang JJ* (2011): Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal. Biomed Phamacother, 45:100-110.17. Kuo YC, Chiu YM, Shih WP, Yu HW, Chen CW, Wong PF, Lin WC, Hwang JJ* (2011): Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Rad Oncol, 6:76-84.18. Hung MC, Hsieh WA,Chang PW, Hwang JJ* (2011): Utilization of nuclear medicine scintigraphy in Taiwan, 1997-2009. Ann Nucl Med, 25: 818-824.19. Kuo YC, Lin WC, Chiang IT, Chang YF, ChenCW, Su SH, Chen CL, Hwang JJ* (2012): Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-kB expression in vitro and in vivo. Biomed Phamacother, 66, 12-20.20. Chang YF, Chuang HY, Hsu CH, Liu RS, Gambhir SS*, Hwang JJ* (2012): Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice. Cancer Prev Res, 5, 444-452.21. Wang WH, Chiang IT, Ding K, Chung JG, Lin WJ, Lin SS, Hwang JJ* (2012): Curcumin-induced apoptosis in human hepatocellular carcinoma J5 cells: critical Role of Ca+2 dependent pathway. Evid-Based Comp Alternative Med, (in press).22. Liu YC, Chiang IT, Hsu FT, Hwang JJ* (2012): Using NF-κB as a molecular target for theranostics in radiation oncology research. Expert Review Mol Dignostics, 12, 139-146.23. Chen HW, Chang YF, Chuang HY, Tai WT, Hwang JJ* (2012): Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc bearing animal model. Pros Cancer Pros Disease (in press).24. Lin WC, ChangYC, ChangCY, ChengYC,Hwang JJ*(2012): Primary lung cancers < 1 cm found with MR screening appeared larger with half-Fourier sequences than with 3-dimensional acquisitioned techniques. Clinical Imaging (in press).25. Hung MC, Chang PW, Hsieh WA,Hwang JJ* (2012): Myocardial perfusion scintigraphy in Taiwan from 2005 to 2009. Nuc Med Comm, (in press).26. Fang CK, Chen HW, Chen CC, Liao JF, Su TP, Tung CY, Uchitomi Y, Hwang JJ* (2012): Mirtazapine inhibits tumor growth via immune response and serotonergic system. PLoS ONE (in press).
-
